{
    "abstract": "Respiratory syncytial virus (RSV) is an important cause of viral lower respiratory tract illness in infants and children globally, but no vaccine is currently available to protect these vulnerable populations. Live-attenuated vaccine approaches have been in development for decades, but achieving the appropriate balance between immunogenicity and safety has proven difficult. Immunoprophylaxis with the neutralizing monoclonal antibody palivizumab is limited to high-risk infants, but cost requirements for multiple dosing make its use impractical in low- and middle-income countries. A growing number of RSV vaccine candidates using a variety of technologies and targeting diverse populations has emerged in recent years. There are now 60 RSV vaccine candidates in development that target pediatric and elderly populations. While most are at a preclinical stage, 16 candidates are in clinical development. This review summarizes current RSV vaccine research and development, including an overview of the vaccine platforms being used, the development stage of individual vaccine candidates, and gaps to be addressed to facilitate use of these vaccines to meet global health needs.",
    "author_highlights": [
        {
            "endOffset": 17539,
            "sentence": "RSV is a significant annual cause of lower respiratory tract illness globally.",
            "startOffset": 17461
        },
        {
            "endOffset": 17617,
            "sentence": "Pediatric and elderly populations are most vulnerable, but no vaccine exists.",
            "startOffset": 17540
        },
        {
            "endOffset": 17690,
            "sentence": "The current state of RSV vaccine research and development is summarized.",
            "startOffset": 17618
        },
        {
            "endOffset": 17769,
            "sentence": "60 RSV vaccine candidates in development, of which 16 are in Phase 1\u20133 trials.",
            "startOffset": 17691
        }
    ],
    "bib_entries": {
        "bib0165": {
            "authors": [
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Lozano"
                },
                {
                    "first": "Mohsen",
                    "initial": "M.",
                    "last": "Naghavi"
                },
                {
                    "first": "Kyle",
                    "initial": "K.",
                    "last": "Foreman"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Lim"
                },
                {
                    "first": "Kenji",
                    "initial": "K.",
                    "last": "Shibuya"
                },
                {
                    "first": "Victor",
                    "initial": "V.",
                    "last": "Aboyans"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Abraham"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Adair"
                },
                {
                    "first": "Rakesh",
                    "initial": "R.",
                    "last": "Aggarwal"
                },
                {
                    "first": "Stephanie Y.",
                    "initial": "S.Y.",
                    "last": "Ahn"
                },
                {
                    "first": "Mohammad A.",
                    "initial": "M.A.",
                    "last": "AlMazroa"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Alvarado"
                },
                {
                    "first": "H. Ross",
                    "initial": "H.R.",
                    "last": "Anderson"
                },
                {
                    "first": "Laurie M.",
                    "initial": "L.M.",
                    "last": "Anderson"
                },
                {
                    "first": "Kathryn G.",
                    "initial": "K.G.",
                    "last": "Andrews"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Atkinson"
                },
                {
                    "first": "Larry M.",
                    "initial": "L.M.",
                    "last": "Baddour"
                },
                {
                    "first": "Suzanne",
                    "initial": "S.",
                    "last": "Barker-Collo"
                },
                {
                    "first": "David H.",
                    "initial": "D.H.",
                    "last": "Bartels"
                },
                {
                    "first": "Michelle L.",
                    "initial": "M.L.",
                    "last": "Bell"
                },
                {
                    "first": "Emelia J.",
                    "initial": "E.J.",
                    "last": "Benjamin"
                },
                {
                    "first": "Derrick",
                    "initial": "D.",
                    "last": "Bennett"
                },
                {
                    "first": "Kavi",
                    "initial": "K.",
                    "last": "Bhalla"
                },
                {
                    "first": "Boris",
                    "initial": "B.",
                    "last": "Bikbov"
                },
                {
                    "first": "Aref",
                    "initial": "A.",
                    "last": "Bin Abdulhak"
                },
                {
                    "first": "Gretchen",
                    "initial": "G.",
                    "last": "Birbeck"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Blyth"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Bolliger"
                },
                {
                    "first": "Soufiane",
                    "initial": "S.",
                    "last": "Boufous"
                },
                {
                    "first": "Chiara",
                    "initial": "C.",
                    "last": "Bucello"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Burch"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Burney"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Carapetis"
                },
                {
                    "first": "Honglei",
                    "initial": "H.",
                    "last": "Chen"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Chou"
                },
                {
                    "first": "Sumeet S.",
                    "initial": "S.S.",
                    "last": "Chugh"
                },
                {
                    "first": "Luc E.",
                    "initial": "L.E.",
                    "last": "Coffeng"
                },
                {
                    "first": "Steven D.",
                    "initial": "S.D.",
                    "last": "Colan"
                },
                {
                    "first": "Samantha",
                    "initial": "S.",
                    "last": "Colquhoun"
                },
                {
                    "first": "K. Ellicott",
                    "initial": "K.E.",
                    "last": "Colson"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Condon"
                },
                {
                    "first": "Myles D.",
                    "initial": "M.D.",
                    "last": "Connor"
                },
                {
                    "first": "Leslie T.",
                    "initial": "L.T.",
                    "last": "Cooper"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Corriere"
                },
                {
                    "first": "Monica",
                    "initial": "M.",
                    "last": "Cortinovis"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Courville De Vaccaro"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Couser"
                },
                {
                    "first": "Benjamin C.",
                    "initial": "B.C.",
                    "last": "Cowie"
                },
                {
                    "first": "Michael H.",
                    "initial": "M.H.",
                    "last": "Criqui"
                },
                {
                    "first": "Marita",
                    "initial": "M.",
                    "last": "Cross"
                },
                {
                    "first": "Kaustubh C.",
                    "initial": "K.C.",
                    "last": "Dabhadkar"
                },
                {
                    "first": "Nabila",
                    "initial": "N.",
                    "last": "Dahodwala"
                },
                {
                    "first": "Diego",
                    "initial": "D.",
                    "last": "De Leo"
                },
                {
                    "first": "Louisa",
                    "initial": "L.",
                    "last": "Degenhardt"
                },
                {
                    "first": "Allyne",
                    "initial": "A.",
                    "last": "Delossantos"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Denenberg"
                },
                {
                    "first": "Don C.",
                    "initial": "D.C.",
                    "last": "Des Jarlais"
                },
                {
                    "first": "Samath D.",
                    "initial": "S.D.",
                    "last": "Dharmaratne"
                },
                {
                    "first": "E. Ray",
                    "initial": "E.R.",
                    "last": "Dorsey"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Driscoll"
                },
                {
                    "first": "Herbert",
                    "initial": "H.",
                    "last": "Duber"
                },
                {
                    "first": "Beth",
                    "initial": "B.",
                    "last": "Ebel"
                },
                {
                    "first": "Patricia J.",
                    "initial": "P.J.",
                    "last": "Erwin"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Espindola"
                },
                {
                    "first": "Majid",
                    "initial": "M.",
                    "last": "Ezzati"
                },
                {
                    "first": "Valery",
                    "initial": "V.",
                    "last": "Feigin"
                },
                {
                    "first": "Abraham D.",
                    "initial": "A.D.",
                    "last": "Flaxman"
                },
                {
                    "first": "Mohammad H.",
                    "initial": "M.H.",
                    "last": "Forouzanfar"
                },
                {
                    "first": "Francis Gerry R.",
                    "initial": "F.G.R.",
                    "last": "Fowkes"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Franklin"
                },
                {
                    "first": "Marlene",
                    "initial": "M.",
                    "last": "Fransen"
                },
                {
                    "first": "Michael K.",
                    "initial": "M.K.",
                    "last": "Freeman"
                },
                {
                    "first": "Sherine E.",
                    "initial": "S.E.",
                    "last": "Gabriel"
                },
                {
                    "first": "Emmanuela",
                    "initial": "E.",
                    "last": "Gakidou"
                },
                {
                    "first": "Flavio",
                    "initial": "F.",
                    "last": "Gaspari"
                },
                {
                    "first": "Richard F.",
                    "initial": "R.F.",
                    "last": "Gillum"
                },
                {
                    "first": "Diego",
                    "initial": "D.",
                    "last": "Gonzalez-Medina"
                },
                {
                    "first": "Yara A.",
                    "initial": "Y.A.",
                    "last": "Halasa"
                },
                {
                    "first": "Diana",
                    "initial": "D.",
                    "last": "Haring"
                },
                {
                    "first": "James E.",
                    "initial": "J.E.",
                    "last": "Harrison"
                },
                {
                    "first": "Rasmus",
                    "initial": "R.",
                    "last": "Havmoeller"
                },
                {
                    "first": "Roderick J.",
                    "initial": "R.J.",
                    "last": "Hay"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Hoen"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Damian",
                    "initial": "D.",
                    "last": "Hoy"
                },
                {
                    "first": "Kathryn H.",
                    "initial": "K.H.",
                    "last": "Jacobsen"
                },
                {
                    "first": "Spencer L.",
                    "initial": "S.L.",
                    "last": "James"
                },
                {
                    "first": "Rashmi",
                    "initial": "R.",
                    "last": "Jasrasaria"
                },
                {
                    "first": "Sudha",
                    "initial": "S.",
                    "last": "Jayaraman"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Johns"
                },
                {
                    "first": "Ganesan",
                    "initial": "G.",
                    "last": "Karthikeyan"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Kassebaum"
                },
                {
                    "first": "Andre",
                    "initial": "A.",
                    "last": "Keren"
                },
                {
                    "first": "Jon Paul",
                    "initial": "J.P.",
                    "last": "Khoo"
                },
                {
                    "first": "Lisa Marie",
                    "initial": "L.M.",
                    "last": "Knowlton"
                },
                {
                    "first": "Olive",
                    "initial": "O.",
                    "last": "Kobusingye"
                },
                {
                    "first": "Adofo",
                    "initial": "A.",
                    "last": "Koranteng"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "Krishnamurthi"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lipnick"
                },
                {
                    "first": "Steven E.",
                    "initial": "S.E.",
                    "last": "Lipshultz"
                },
                {
                    "first": "Summer",
                    "initial": "S.",
                    "last": "Lockett Ohno"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Mabweijano"
                },
                {
                    "first": "Michael F.",
                    "initial": "M.F.",
                    "last": "MacIntyre"
                },
                {
                    "first": "Leslie",
                    "initial": "L.",
                    "last": "Mallinger"
                },
                {
                    "first": "Lyn",
                    "initial": "L.",
                    "last": "March"
                },
                {
                    "first": "Guy B.",
                    "initial": "G.B.",
                    "last": "Marks"
                },
                {
                    "first": "Robin",
                    "initial": "R.",
                    "last": "Marks"
                },
                {
                    "first": "Akira",
                    "initial": "A.",
                    "last": "Matsumori"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Matzopoulos"
                },
                {
                    "first": "Bongani M.",
                    "initial": "B.M.",
                    "last": "Mayosi"
                },
                {
                    "first": "John H.",
                    "initial": "J.H.",
                    "last": "McAnulty"
                },
                {
                    "first": "Mary M.",
                    "initial": "M.M.",
                    "last": "McDermott"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "McGrath"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "George A.",
                    "initial": "G.A.",
                    "last": "Mensah"
                },
                {
                    "first": "Tony R.",
                    "initial": "T.R.",
                    "last": "Merriman"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Michaud"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Miller"
                },
                {
                    "first": "Ted R.",
                    "initial": "T.R.",
                    "last": "Miller"
                },
                {
                    "first": "Charles",
                    "initial": "C.",
                    "last": "Mock"
                },
                {
                    "first": "Ana Olga",
                    "initial": "A.O.",
                    "last": "Mocumbi"
                },
                {
                    "first": "Ali A.",
                    "initial": "A.A.",
                    "last": "Mokdad"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Moran"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Mulholland"
                },
                {
                    "first": "M. Nathan",
                    "initial": "M.N.",
                    "last": "Nair"
                },
                {
                    "first": "Luigi",
                    "initial": "L.",
                    "last": "Naldi"
                },
                {
                    "first": "K. M.Venkat",
                    "initial": "K.M.V.",
                    "last": "Narayan"
                },
                {
                    "first": "Kiumarss",
                    "initial": "K.",
                    "last": "Nasseri"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Norman"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "O'Donnell"
                },
                {
                    "first": "Saad B.",
                    "initial": "S.B.",
                    "last": "Omer"
                },
                {
                    "first": "Katrina",
                    "initial": "K.",
                    "last": "Ortblad"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Osborne"
                },
                {
                    "first": "Doruk",
                    "initial": "D.",
                    "last": "Ozgediz"
                },
                {
                    "first": "Bishnu",
                    "initial": "B.",
                    "last": "Pahari"
                },
                {
                    "first": "Jeyaraj Durai",
                    "initial": "J.D.",
                    "last": "Pandian"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Panozo Rivero"
                },
                {
                    "first": "Rogelio",
                    "initial": "R.",
                    "last": "Perez Padilla"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Perez-Ruiz"
                },
                {
                    "first": "Norberto",
                    "initial": "N.",
                    "last": "Perico"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Phillips"
                },
                {
                    "first": "Kelsey",
                    "initial": "K.",
                    "last": "Pierce"
                },
                {
                    "first": "C. Arden",
                    "initial": "C.A.",
                    "last": "Pope"
                },
                {
                    "first": "Esteban",
                    "initial": "E.",
                    "last": "Porrini"
                },
                {
                    "first": "Farshad",
                    "initial": "F.",
                    "last": "Pourmalek"
                },
                {
                    "first": "Murugesan",
                    "initial": "M.",
                    "last": "Raju"
                },
                {
                    "first": "Dharani",
                    "initial": "D.",
                    "last": "Ranganathan"
                },
                {
                    "first": "J\u00fcrgen T.",
                    "initial": "J.T.",
                    "last": "Rehm"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Rein"
                },
                {
                    "first": "Guiseppe",
                    "initial": "G.",
                    "last": "Remuzzi"
                },
                {
                    "first": "Frederick P.",
                    "initial": "F.P.",
                    "last": "Rivara"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Roberts"
                },
                {
                    "first": "Felipe",
                    "initial": "F.",
                    "last": "Rodriguez De Le\u00f3n"
                },
                {
                    "first": "Lisa C.",
                    "initial": "L.C.",
                    "last": "Rosenfeld"
                },
                {
                    "first": "Lesley",
                    "initial": "L.",
                    "last": "Rushton"
                },
                {
                    "first": "Ralph L.",
                    "initial": "R.L.",
                    "last": "Sacco"
                },
                {
                    "first": "Joshua A.",
                    "initial": "J.A.",
                    "last": "Salomon"
                },
                {
                    "first": "Uchechukwu",
                    "initial": "U.",
                    "last": "Sampson"
                },
                {
                    "first": "Ella",
                    "initial": "E.",
                    "last": "Sanman"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Schwebel"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Segui-Gomez"
                },
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Singh"
                },
                {
                    "first": "Jessica",
                    "initial": "J.",
                    "last": "Singleton"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Sliwa"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Smith"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Steer"
                },
                {
                    "first": "Jennifer A.",
                    "initial": "J.A.",
                    "last": "Taylor"
                },
                {
                    "first": "Bernadette",
                    "initial": "B.",
                    "last": "Thomas"
                },
                {
                    "first": "Imad M.",
                    "initial": "I.M.",
                    "last": "Tleyjeh"
                },
                {
                    "first": "Jeffrey A.",
                    "initial": "J.A.",
                    "last": "Towbin"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Truelsen"
                },
                {
                    "first": "Eduardo A.",
                    "initial": "E.A.",
                    "last": "Undurraga"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Venketasubramanian"
                },
                {
                    "first": "Lakshmi",
                    "initial": "L.",
                    "last": "Vijayakumar"
                },
                {
                    "first": "Theo",
                    "initial": "T.",
                    "last": "Vos"
                },
                {
                    "first": "Gregory R.",
                    "initial": "G.R.",
                    "last": "Wagner"
                },
                {
                    "first": "Mengru",
                    "initial": "M.",
                    "last": "Wang"
                },
                {
                    "first": "Wenzhi",
                    "initial": "W.",
                    "last": "Wang"
                },
                {
                    "first": "Kerrianne",
                    "initial": "K.",
                    "last": "Watt"
                },
                {
                    "first": "Martin A.",
                    "initial": "M.A.",
                    "last": "Weinstock"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Weintraub"
                },
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Anthony D.",
                    "initial": "A.D.",
                    "last": "Woolf"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Wulf"
                },
                {
                    "first": "Pon Hsiu",
                    "initial": "P.H.",
                    "last": "Yeh"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Yip"
                },
                {
                    "first": "Azadeh",
                    "initial": "A.",
                    "last": "Zabetian"
                },
                {
                    "first": "Zhi Jie",
                    "initial": "Z.J.",
                    "last": "Zheng"
                },
                {
                    "first": "Alan D.",
                    "initial": "A.D.",
                    "last": "Lopez"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                }
            ],
            "doi": "10.1016/S0140-6736(12)61728-0",
            "firstpage": "2095",
            "issn": "01406736",
            "lastpage": "2128",
            "pmid": "23245604",
            "pub_year": 2012,
            "title": "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010",
            "volume": "380"
        },
        "bib0170": {
            "authors": [
                {
                    "first": "Ann R.",
                    "initial": "A.R.",
                    "last": "Falsey"
                },
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Hennessey"
                },
                {
                    "first": "Maria A.",
                    "initial": "M.A.",
                    "last": "Formica"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Cox"
                },
                {
                    "first": "Edward E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                }
            ],
            "doi": "10.1056/NEJMoa043951",
            "firstpage": "1749",
            "issn": "00284793",
            "lastpage": "1759",
            "pmid": "15858184",
            "pub_year": 2005,
            "title": "Respiratory syncytial virus infection in elderly and high-risk adults",
            "volume": "352"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Caroline Breese",
                    "initial": "C.B.",
                    "last": "Hall"
                }
            ],
            "firstpage": "92",
            "issn": "18715265",
            "lastpage": "97",
            "pmid": "22335498",
            "pub_year": 2012,
            "title": "The burgeoning burden of Respiratory syncytial virus among children",
            "volume": "12"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Dudas"
                },
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Karron"
                }
            ],
            "doi": "10.1128/cmr.11.3.430",
            "firstpage": "430",
            "issn": "08938512",
            "lastpage": "439",
            "pmid": "9665976",
            "pub_year": 1998,
            "title": "Respiratory syncytial virus vaccines",
            "volume": "11"
        },
        "bib0185": {
            "authors": [
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": "D. James",
                    "initial": "D.J.",
                    "last": "Nokes"
                },
                {
                    "first": "Bradford D.",
                    "initial": "B.D.",
                    "last": "Gessner"
                },
                {
                    "first": "Mukesh",
                    "initial": "M.",
                    "last": "Dherani"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Rosalyn J.",
                    "initial": "R.J.",
                    "last": "Singleton"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Roca"
                },
                {
                    "first": "Peter F.",
                    "initial": "P.F.",
                    "last": "Wright"
                },
                {
                    "first": "Nigel",
                    "initial": "N.",
                    "last": "Bruce"
                },
                {
                    "first": "Aruna",
                    "initial": "A.",
                    "last": "Chandran"
                },
                {
                    "first": "Evropi",
                    "initial": "E.",
                    "last": "Theodoratou"
                },
                {
                    "first": "Agustinus",
                    "initial": "A.",
                    "last": "Sutanto"
                },
                {
                    "first": "Endang R.",
                    "initial": "E.R.",
                    "last": "Sedyaningsih"
                },
                {
                    "first": "Mwanajuma",
                    "initial": "M.",
                    "last": "Ngama"
                },
                {
                    "first": "Patrick K.",
                    "initial": "P.K.",
                    "last": "Munywoki"
                },
                {
                    "first": "Cissy",
                    "initial": "C.",
                    "last": "Kartasasmita"
                },
                {
                    "first": "Eric AF",
                    "initial": "E.A.",
                    "last": "Sim\u00f5es"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Rudan"
                },
                {
                    "first": "Martin W.",
                    "initial": "M.W.",
                    "last": "Weber"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                }
            ],
            "doi": "10.1016/S0140-6736(10)60206-1",
            "firstpage": "1545",
            "issn": "01406736",
            "lastpage": "1555",
            "pmid": "20399493",
            "pub_year": 2010,
            "title": "Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis",
            "volume": "375"
        },
        "bib0190": null,
        "bib0195": {
            "authors": [
                {
                    "first": "L. J.",
                    "initial": "L.J.",
                    "last": "Anderson"
                },
                {
                    "first": "P. R.",
                    "initial": "P.R.",
                    "last": "Dormitzer"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Nokes"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Roca"
                },
                {
                    "first": "B. S.",
                    "initial": "B.S.",
                    "last": "Graham"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.11.106",
            "firstpage": "B209",
            "issn": "0264410X",
            "lastpage": "B215",
            "pmid": "23598484",
            "pub_year": 2013,
            "title": "Strategic priorities for respiratory syncytial virus (RSV) vaccine development",
            "volume": "31"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Connors"
                },
                {
                    "first": "Peter L.",
                    "initial": "P.L.",
                    "last": "Collins"
                },
                {
                    "first": "Cai Yen",
                    "initial": "C.Y.",
                    "last": "Firestone"
                },
                {
                    "first": "Alex V.",
                    "initial": "A.V.",
                    "last": "Sotnikov"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Waitze"
                },
                {
                    "first": "Alan R.",
                    "initial": "A.R.",
                    "last": "Davis"
                },
                {
                    "first": "Paul P.",
                    "initial": "P.P.",
                    "last": "Hung"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                },
                {
                    "first": "Brian R.",
                    "initial": "B.R.",
                    "last": "Murphy"
                }
            ],
            "doi": "10.1016/0264-410X(92)90397-3",
            "firstpage": "475",
            "issn": "0264410X",
            "lastpage": "484",
            "pmid": "1609551",
            "pub_year": 1992,
            "title": "Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV",
            "volume": "10"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Jessie R.",
                    "initial": "J.R.",
                    "last": "Groothuis"
                },
                {
                    "first": "J. Michael",
                    "initial": "J.M.",
                    "last": "Hoopes"
                },
                {
                    "first": "Val G.",
                    "initial": "V.G.",
                    "last": "Hemming"
                }
            ],
            "doi": "10.1007/s12325-010-0101-y",
            "firstpage": "110",
            "issn": "0741238X",
            "lastpage": "125",
            "pmid": "21318605",
            "pub_year": 2011,
            "title": "Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis",
            "volume": "28"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "W. Paul",
                    "initial": "W.P.",
                    "last": "Glezen"
                },
                {
                    "first": "Abel",
                    "initial": "A.",
                    "last": "Paredes"
                },
                {
                    "first": "James E.",
                    "initial": "J.E.",
                    "last": "Allison"
                },
                {
                    "first": "Larry H.",
                    "initial": "L.H.",
                    "last": "Taber"
                },
                {
                    "first": "Arthur L.",
                    "initial": "A.L.",
                    "last": "Frank"
                }
            ],
            "doi": "10.1016/S0022-3476(81)80829-3",
            "firstpage": "708",
            "issn": "00223476",
            "lastpage": "715",
            "pub_year": 1981,
            "title": "Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level",
            "volume": "98"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Chin"
                },
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Magoffin"
                },
                {
                    "first": "Lois Ann",
                    "initial": "L.A.",
                    "last": "Shearer"
                },
                {
                    "first": "Jack H.",
                    "initial": "J.H.",
                    "last": "Schieble"
                },
                {
                    "first": "Edwin H.",
                    "initial": "E.H.",
                    "last": "Lennette"
                }
            ],
            "doi": "10.1093/oxfordjournals.aje.a120957",
            "firstpage": "449",
            "issn": "00029262",
            "lastpage": "463",
            "pmid": "4305200",
            "pub_year": 1969,
            "title": "Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population",
            "volume": "89"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "V. A.",
                    "initial": "V.A.",
                    "last": "Fulginiti"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Eller"
                },
                {
                    "first": "O. F.",
                    "initial": "O.F.",
                    "last": "Sieber"
                },
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Joyner"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Minamitani"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Meiklejohn"
                }
            ],
            "doi": "10.1093/oxfordjournals.aje.a120956",
            "firstpage": "435",
            "issn": "00029262",
            "lastpage": "448",
            "pmid": "4305199",
            "pub_year": 1969,
            "title": "Respiratory virus immunization: A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent paratnfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine",
            "volume": "89"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Albert Z.",
                    "initial": "A.Z.",
                    "last": "Kapikian"
                },
                {
                    "first": "Reginald H.",
                    "initial": "R.H.",
                    "last": "Mitchell"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                },
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Shvedoff"
                },
                {
                    "first": "C. Eleanor",
                    "initial": "C.E.",
                    "last": "Stewart"
                }
            ],
            "doi": "10.1093/oxfordjournals.aje.a120954",
            "firstpage": "405",
            "issn": "00029262",
            "lastpage": "421",
            "pmid": "4305197",
            "pub_year": 1969,
            "title": "An epidemiologic study of altered clinical reactivity to Respiratory Syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine",
            "volume": "89"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Hyun Wha",
                    "initial": "H.W.",
                    "last": "Kim"
                },
                {
                    "first": "Jose G.",
                    "initial": "J.G.",
                    "last": "Canchola"
                },
                {
                    "first": "Carl D.",
                    "initial": "C.D.",
                    "last": "Brandt"
                },
                {
                    "first": "Gloria",
                    "initial": "G.",
                    "last": "Pyles"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Jensen"
                },
                {
                    "first": "Robert H.",
                    "initial": "R.H.",
                    "last": "Parrott"
                }
            ],
            "doi": "10.1093/oxfordjournals.aje.a120955",
            "firstpage": "422",
            "issn": "00029262",
            "lastpage": "434",
            "pmid": "4305198",
            "pub_year": 1969,
            "title": "Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine",
            "volume": "89"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "H. W.",
                    "initial": "H.W.",
                    "last": "Kim"
                },
                {
                    "first": "S. L.",
                    "initial": "S.L.",
                    "last": "Leikin"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Arrobio"
                },
                {
                    "first": "C. D.",
                    "initial": "C.D.",
                    "last": "Brandt"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                },
                {
                    "first": "R. H.",
                    "initial": "R.H.",
                    "last": "Parrott"
                }
            ],
            "doi": "10.1203/00006450-197601000-00015",
            "firstpage": "75",
            "issn": "00313998",
            "lastpage": "78",
            "pub_year": 1976,
            "title": "Cell mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection",
            "volume": "10"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "B. R.",
                    "initial": "B.R.",
                    "last": "Murphy"
                },
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "E. E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                }
            ],
            "firstpage": "197",
            "issn": "00951137",
            "lastpage": "202",
            "pmid": "3755730",
            "pub_year": 1986,
            "title": "Dissociation betwen serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine",
            "volume": "24"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Fernando P.",
                    "initial": "F.P.",
                    "last": "Polack"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Teng"
                },
                {
                    "first": "Peter L.",
                    "initial": "P.L.",
                    "last": "Collins"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "Marcus",
                    "initial": "M.",
                    "last": "Exner"
                },
                {
                    "first": "Heinz",
                    "initial": "H.",
                    "last": "Regele"
                },
                {
                    "first": "Dario D.",
                    "initial": "D.D.",
                    "last": "Lirman"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Rabold"
                },
                {
                    "first": "Scott J.",
                    "initial": "S.J.",
                    "last": "Hoffman"
                },
                {
                    "first": "Christopher L.",
                    "initial": "C.L.",
                    "last": "Karp"
                },
                {
                    "first": "Steven R.",
                    "initial": "S.R.",
                    "last": "Kleeberger"
                },
                {
                    "first": "Marsha",
                    "initial": "M.",
                    "last": "Wills-Karp"
                },
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Karron"
                }
            ],
            "doi": "10.1084/jem.20020781",
            "firstpage": "859",
            "issn": "00221007",
            "lastpage": "865",
            "pmid": "12235218",
            "pub_year": 2002,
            "title": "A role for immune complexes in enhanced respiratory syncytial virus disease",
            "volume": "196"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Brian R.",
                    "initial": "B.R.",
                    "last": "Murphy"
                },
                {
                    "first": "Alex V.",
                    "initial": "A.V.",
                    "last": "Sotnikov"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Lawrence"
                },
                {
                    "first": "Steven M.",
                    "initial": "S.M.",
                    "last": "Banks"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Prince"
                }
            ],
            "doi": "10.1016/0264-410X(90)90253-I",
            "firstpage": "497",
            "issn": "0264410X",
            "lastpage": "502",
            "pmid": "2251875",
            "pub_year": 1990,
            "title": "Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization",
            "volume": "8"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Curtis"
                },
                {
                    "first": "K. C.",
                    "initial": "K.C.",
                    "last": "Yim"
                },
                {
                    "first": "D. D.",
                    "initial": "D.D.",
                    "last": "Porter"
                }
            ],
            "doi": "10.1099/0022-1317-82-12-2881",
            "firstpage": "2881",
            "issn": "00221317",
            "lastpage": "2888",
            "pmid": "11714962",
            "pub_year": 2001,
            "title": "Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine",
            "volume": "82"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "A. B.",
                    "initial": "A.B.",
                    "last": "Jenson"
                },
                {
                    "first": "V. G.",
                    "initial": "V.G.",
                    "last": "Hemming"
                },
                {
                    "first": "B. R.",
                    "initial": "B.R.",
                    "last": "Murphy"
                },
                {
                    "first": "E. E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                },
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Horswood"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                }
            ],
            "doi": "10.1128/jvi.57.3.721-728.1986",
            "firstpage": "721",
            "issn": "0022538X",
            "lastpage": "728",
            "pmid": "2419587",
            "pub_year": 1986,
            "title": "Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of Formalin-inactivated virus",
            "volume": "57"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Caroline Breese",
                    "initial": "C.B.",
                    "last": "Hall"
                },
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Marika K.",
                    "initial": "M.K.",
                    "last": "Iwane"
                },
                {
                    "first": "Aaron K.",
                    "initial": "A.K.",
                    "last": "Blumkin"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Mary A.",
                    "initial": "M.A.",
                    "last": "Staat"
                },
                {
                    "first": "Peggy",
                    "initial": "P.",
                    "last": "Auinger"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Poehling"
                },
                {
                    "first": "Dean",
                    "initial": "D.",
                    "last": "Erdman"
                },
                {
                    "first": "Carlos G.",
                    "initial": "C.G.",
                    "last": "Grijalva"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Szilagyi"
                }
            ],
            "doi": "10.1056/NEJMoa0804877",
            "firstpage": "588",
            "issn": "00284793",
            "lastpage": "598",
            "pmid": "19196675",
            "pub_year": 2009,
            "title": "The Burden of respiratory syncytial virus infection in young children",
            "volume": "360"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Karron"
                },
                {
                    "first": "Cindy",
                    "initial": "C.",
                    "last": "Luongo"
                },
                {
                    "first": "Bhagvanji",
                    "initial": "B.",
                    "last": "Thumar"
                },
                {
                    "first": "Karen M.",
                    "initial": "K.M.",
                    "last": "Loehr"
                },
                {
                    "first": "Janet A.",
                    "initial": "J.A.",
                    "last": "Englund"
                },
                {
                    "first": "Peter L.",
                    "initial": "P.L.",
                    "last": "Collins"
                },
                {
                    "first": "Ursula J.",
                    "initial": "U.J.",
                    "last": "Buchholz"
                }
            ],
            "doi": "10.1126/scitranslmed.aac8463",
            "issn": "19466234",
            "pmid": "26537255",
            "pub_year": 2015,
            "title": "A gene deletion that up-regulates viral gene expression yields an attenuated RSV vaccine with improved antibody responses in children",
            "volume": "7"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Leonard B.",
                    "initial": "L.B.",
                    "last": "Bacharier"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Cohen"
                },
                {
                    "first": "Toni",
                    "initial": "T.",
                    "last": "Schweiger"
                },
                {
                    "first": "Huiquing",
                    "initial": "H.",
                    "last": "Yin-Declue"
                },
                {
                    "first": "Chandrika",
                    "initial": "C.",
                    "last": "Christie"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Zheng"
                },
                {
                    "first": "Kenneth B.",
                    "initial": "K.B.",
                    "last": "Schechtman"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Strunk"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Castro"
                }
            ],
            "doi": "10.1016/j.jaci.2012.02.010",
            "firstpage": "91",
            "issn": "00916749",
            "lastpage": "e3",
            "pub_year": 2012,
            "title": "Determinants of asthma after severe respiratory syncytial virus bronchiolitis",
            "volume": "130"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "Astrid A.T.M.",
                    "initial": "A.A.T.M.",
                    "last": "Bosch"
                },
                {
                    "first": "Giske",
                    "initial": "G.",
                    "last": "Biesbroek"
                },
                {
                    "first": "Krzysztof",
                    "initial": "K.",
                    "last": "Trzcinski"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                },
                {
                    "first": "Debby",
                    "initial": "D.",
                    "last": "Bogaert"
                }
            ],
            "doi": "10.1371/journal.ppat.1003057",
            "issn": "15537366",
            "pmid": "23326226",
            "pub_year": 2013,
            "title": "Viral and Bacterial Interactions in the Upper Respiratory Tract",
            "volume": "9"
        },
        "bib0285": {
            "authors": [
                {
                    "first": "Kayvon",
                    "initial": "K.",
                    "last": "Modjarrad"
                },
                {
                    "first": "Birgitte",
                    "initial": "B.",
                    "last": "Giersing"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Kaslow"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Smith"
                },
                {
                    "first": "Vasee S.",
                    "initial": "V.S.",
                    "last": "Moorthy"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.05.093",
            "firstpage": "190",
            "issn": "0264410X",
            "lastpage": "197",
            "pmid": "26100926",
            "pub_year": 2016,
            "title": "WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015",
            "volume": "34"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "Gregory M.",
                    "initial": "G.M.",
                    "last": "Glenn"
                },
                {
                    "first": "Gale",
                    "initial": "G.",
                    "last": "Smith"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Fries"
                },
                {
                    "first": "Rama",
                    "initial": "R.",
                    "last": "Raghunandan"
                },
                {
                    "first": "Hanxin",
                    "initial": "H.",
                    "last": "Lu"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Zhou"
                },
                {
                    "first": "D. Nigel",
                    "initial": "D.N.",
                    "last": "Thomas"
                },
                {
                    "first": "Somia P.",
                    "initial": "S.P.",
                    "last": "Hickman"
                },
                {
                    "first": "Eloi",
                    "initial": "E.",
                    "last": "Kpamegan"
                },
                {
                    "first": "Sarathi",
                    "initial": "S.",
                    "last": "Boddapati"
                },
                {
                    "first": "Pedro A.",
                    "initial": "P.A.",
                    "last": "Piedra"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.11.009",
            "firstpage": "524",
            "issn": "0264410X",
            "lastpage": "532",
            "pmid": "23153449",
            "pub_year": 2013,
            "title": "Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine",
            "volume": "31"
        },
        "bib0295": {
            "authors": [
                {
                    "first": "Jessie R.",
                    "initial": "J.R.",
                    "last": "Groothuis"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Simoes"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Caroline B.",
                    "initial": "C.B.",
                    "last": "Hall"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Long"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Rodriguez"
                },
                {
                    "first": "Julita",
                    "initial": "J.",
                    "last": "Arrobio"
                },
                {
                    "first": "H. Cody",
                    "initial": "H.C.",
                    "last": "Meissner"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Fulton"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Welliver"
                },
                {
                    "first": "Debra A.",
                    "initial": "D.A.",
                    "last": "Tristram"
                },
                {
                    "first": "George R.",
                    "initial": "G.R.",
                    "last": "Siber"
                },
                {
                    "first": "Gregory A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Van Raden"
                },
                {
                    "first": "Val G.",
                    "initial": "V.G.",
                    "last": "Hemming"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJM199311183292102",
            "firstpage": "1524",
            "issn": "00284793",
            "lastpage": "1530",
            "pmid": "8413475",
            "pub_year": 1993,
            "title": "Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children",
            "volume": "329"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Prince"
                },
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Horswood"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Chanock"
                }
            ],
            "firstpage": "517",
            "issn": "0022538X",
            "lastpage": "520",
            "pmid": "4020957",
            "pub_year": 1985,
            "title": "Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats",
            "volume": "55"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "E. E.",
                    "initial": "E.E.",
                    "last": "Walsh"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Schlesinger"
                },
                {
                    "first": "M. W.",
                    "initial": "M.W.",
                    "last": "Brandriss"
                }
            ],
            "doi": "10.1128/iai.43.2.756-758.1984",
            "firstpage": "756",
            "issn": "00199567",
            "lastpage": "758",
            "pmid": "6363300",
            "pub_year": 1984,
            "title": "Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies",
            "volume": "43"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "Lassi",
                    "initial": "L.",
                    "last": "Liljeroos"
                },
                {
                    "first": "Magdalena Anna",
                    "initial": "M.A.",
                    "last": "Krzyzaniak"
                },
                {
                    "first": "Ari",
                    "initial": "A.",
                    "last": "Helenius"
                },
                {
                    "first": "Sarah Jane",
                    "initial": "S.J.",
                    "last": "Butcher"
                }
            ],
            "doi": "10.1073/pnas.1309070110",
            "firstpage": "11133",
            "issn": "00278424",
            "lastpage": "11138",
            "pmid": "23776214",
            "pub_year": 2013,
            "title": "Architecture of respiratory syncytial virus revealed by electron cryotomography",
            "volume": "110"
        },
        "bib0315": {
            "authors": [
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "McLellan"
                },
                {
                    "first": "Man",
                    "initial": "M.",
                    "last": "Chen"
                },
                {
                    "first": "M. Gordon",
                    "initial": "M.G.",
                    "last": "Joyce"
                },
                {
                    "first": "Mallika",
                    "initial": "M.",
                    "last": "Sastry"
                },
                {
                    "first": "Guillaume B.E.",
                    "initial": "G.B.E.",
                    "last": "Stewart-Jones"
                },
                {
                    "first": "Yongping",
                    "initial": "Y.",
                    "last": "Yang"
                },
                {
                    "first": "Baoshan",
                    "initial": "B.",
                    "last": "Zhang"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Chen"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Srivatsan"
                },
                {
                    "first": "Anqi",
                    "initial": "A.",
                    "last": "Zheng"
                },
                {
                    "first": "Tongqing",
                    "initial": "T.",
                    "last": "Zhou"
                },
                {
                    "first": "Kevin W.",
                    "initial": "K.W.",
                    "last": "Graepel"
                },
                {
                    "first": "Azad",
                    "initial": "A.",
                    "last": "Kumar"
                },
                {
                    "first": "Syed",
                    "initial": "S.",
                    "last": "Moin"
                },
                {
                    "first": "Jeffrey C.",
                    "initial": "J.C.",
                    "last": "Boyington"
                },
                {
                    "first": "Gwo Yu",
                    "initial": "G.Y.",
                    "last": "Chuang"
                },
                {
                    "first": "Cinque",
                    "initial": "C.",
                    "last": "Soto"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Baxa"
                },
                {
                    "first": "Arjen Q.",
                    "initial": "A.Q.",
                    "last": "Bakker"
                },
                {
                    "first": "Hergen",
                    "initial": "H.",
                    "last": "Spits"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Beaumont"
                },
                {
                    "first": "Zizheng",
                    "initial": "Z.",
                    "last": "Zheng"
                },
                {
                    "first": "Ningshao",
                    "initial": "N.",
                    "last": "Xia"
                },
                {
                    "first": "Sung Youl",
                    "initial": "S.Y.",
                    "last": "Ko"
                },
                {
                    "first": "John Paul",
                    "initial": "J.P.",
                    "last": "Todd"
                },
                {
                    "first": "Srinivas",
                    "initial": "S.",
                    "last": "Rao"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                }
            ],
            "doi": "10.1126/science.1243283",
            "firstpage": "592",
            "issn": "00368075",
            "lastpage": "598",
            "pub_year": 2013,
            "title": "Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus",
            "volume": "342"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Joan O.",
                    "initial": "J.O.",
                    "last": "Ngwuta"
                },
                {
                    "first": "Man",
                    "initial": "M.",
                    "last": "Chen"
                },
                {
                    "first": "Kayvon",
                    "initial": "K.",
                    "last": "Modjarrad"
                },
                {
                    "first": "M. Gordon",
                    "initial": "M.G.",
                    "last": "Joyce"
                },
                {
                    "first": "Masaru",
                    "initial": "M.",
                    "last": "Kanekiyo"
                },
                {
                    "first": "Azad",
                    "initial": "A.",
                    "last": "Kumar"
                },
                {
                    "first": "Hadi M.",
                    "initial": "H.M.",
                    "last": "Yassine"
                },
                {
                    "first": "Syed M.",
                    "initial": "S.M.",
                    "last": "Moin"
                },
                {
                    "first": "April M.",
                    "initial": "A.M.",
                    "last": "Killikelly"
                },
                {
                    "first": "Gwo Yu",
                    "initial": "G.Y.",
                    "last": "Chuang"
                },
                {
                    "first": "Aliaksandr",
                    "initial": "A.",
                    "last": "Druz"
                },
                {
                    "first": "Ivelin S.",
                    "initial": "I.S.",
                    "last": "Georgiev"
                },
                {
                    "first": "Emily J.",
                    "initial": "E.J.",
                    "last": "Rundlet"
                },
                {
                    "first": "Mallika",
                    "initial": "M.",
                    "last": "Sastry"
                },
                {
                    "first": "Guillaume B.E.",
                    "initial": "G.B.E.",
                    "last": "Stewart-Jones"
                },
                {
                    "first": "Yongping",
                    "initial": "Y.",
                    "last": "Yang"
                },
                {
                    "first": "Baoshan",
                    "initial": "B.",
                    "last": "Zhang"
                },
                {
                    "first": "Martha C.",
                    "initial": "M.C.",
                    "last": "Nason"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Capella"
                },
                {
                    "first": "Mark E.",
                    "initial": "M.E.",
                    "last": "Peeples"
                },
                {
                    "first": "Julie E.",
                    "initial": "J.E.",
                    "last": "Ledgerwood"
                },
                {
                    "first": "Jason S.",
                    "initial": "J.S.",
                    "last": "McLellan"
                },
                {
                    "first": "Peter D.",
                    "initial": "P.D.",
                    "last": "Kwong"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                }
            ],
            "doi": "10.1126/scitranslmed.aac4241",
            "issn": "19466234",
            "pmid": "26468324",
            "pub_year": 2015,
            "title": "Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera",
            "volume": "7"
        }
    },
    "body_text": [
        {
            "endOffset": 41562,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Several other RSV F protein-based candidates with or without alum adjuvant are currently being developed for maternal immunization.",
            "startOffset": 41431,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 27543,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Recent approaches include engineered viruses that use knowledge of RSV gene function to create \u2018knock-out\u2019 viruses that are attenuated but still immunogenic, such as the M2-2 deletion mutant that favors transcription over replication of the genome, leading to more protein production, but limited virus production.",
            "startOffset": 27229,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 29582,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Genetic modifications that increase potency and half-life may provide protection for an entire RSV season with just a single dose.",
            "startOffset": 29452,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 26746,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The legacy of ERD led to hesitancy from vaccine developers, clinical investigators, and regulators for use of RSV vaccines requiring MHC class II processing in RSV-na\u00efve infants.",
            "startOffset": 26568,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 40802,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Preclinical vaccine developers include pharmaceutical companies, government agencies, academic institutions, and biotechnology organizations targeting infant, child, and elderly populations (Fig. 1).",
            "startOffset": 40603,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 42368,
            "parents": [],
            "secId": "sec0025",
            "sentence": "These two enhanced features may make protecting newborns through their first RSV season with a single dose possible, which could provide an alternative to maternal immunization for high-, middle-, and low-income countries.",
            "startOffset": 42146,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 24018,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Infections recur throughout life but, as natural immunity increases, the disease becomes less severe so that older children and healthy younger adults typically experience a mild upper respiratory illness.",
            "startOffset": 23813,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 25942,
            "parents": [],
            "secId": "sec0010",
            "sentence": "The severe lung inflammation, worsened disease, and deaths that occurred in vaccines raised concerns that other non-replicating RSV vaccines might also predispose infants and RSV-na\u00efve children to aberrant immune responses.",
            "startOffset": 25719,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 32589,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "In children with respiratory co-morbidities (e.g., asthma, congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis), an effective RSV vaccine could have significant impact on morbidity.",
            "startOffset": 32390,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 31729,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "This approach would bypass the challenge of adequately attenuating live candidates for newborns, and the optimal time for active immunization will depend on the duration of protection afforded by passive immunization.",
            "startOffset": 31512,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 35334,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Pathways for pediatric vaccines using a live-attenuated approach could likewise follow established pre-existing pathways.",
            "startOffset": 35213,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 40143,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Novavax recently initiated late stage development of both elderly and maternal immunization vaccine candidates (Phase 3), and advanced a pediatric candidate into the clinic (Phase 1).",
            "startOffset": 39960,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 32717,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "There are reports that up to 50 percent of children who suffer severe RSV bronchiolitis are subsequently diagnosed with asthma.",
            "startOffset": 32590,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 26404,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 26403,
                    "startOffset": 26394
                },
                "bib0235": {
                    "endOffset": 26403,
                    "startOffset": 26394
                },
                "bib0240": {
                    "endOffset": 26403,
                    "startOffset": 26394
                },
                "bib0245": {
                    "endOffset": 26403,
                    "startOffset": 26394
                }
            },
            "secId": "sec0010",
            "sentence": "These types of immunologic responses can lead to immune complex deposition and complement activation and allergic inflammation [8,15\u201317].",
            "startOffset": 26267,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 24920,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Although serum neutralizing antibody clearly protect against RSV-associated ALRI, other types of immunity (e.g., mucosal antibody cell-mediated immunity) may also contribute and be induced by certain vaccines (e.g., DNA, vector).",
            "startOffset": 24691,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 26114,
            "parents": [],
            "secId": "sec0010",
            "sentence": "However, the immunization of older children with the FI-RSV vaccine did not result in enhanced disease as prior infection had primed for a non-deleterious immune response.",
            "startOffset": 25943,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 27228,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Live-attenuated RSV vaccines to protect pediatric populations from RSV disease have been in development for decades and do not appear to cause enhanced disease in RSV-na\u00efve infants.",
            "startOffset": 27047,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 39755,
            "parents": [],
            "secId": "sec0025",
            "sentence": "These were the primary candidates in clinical testing for many years, but recently there has been a significant surge in RSV vaccine candidates using other platforms.",
            "startOffset": 39589,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 25062,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 25061,
                    "startOffset": 25057
                }
            },
            "secId": "sec0005",
            "sentence": "A reduced incidence of RSV ALRI during the first months of life correlates with higher concentrations of RSV-specific maternal antibody [10].",
            "startOffset": 24921,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 27699,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Naturally attenuated chimeric viruses combining genes from RSV-related viruses such as Sendai, parainfluenza virus, and bovine RSV are also in development.",
            "startOffset": 27544,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 34580,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "A maternal immunization pathway could start with healthy non-pregnant women of child bearing age, advancing to pregnant women with safety follow-up in both mother and infant.",
            "startOffset": 34406,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 40334,
            "parents": [],
            "secId": "sec0025",
            "sentence": "GlaxoSmithKline (GSK, Phase 2), GSK (legacy Novartis, Phase 1), and MedImmune (Phase 2) are also testing RSV F candidates for use in maternal immunization and/or immunization of the elderly.",
            "startOffset": 40144,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 42145,
            "parents": [],
            "secId": "sec0025",
            "sentence": "MedImmune is advancing a post-F subunit candidate vaccine for the elderly population (Phase 2), and is testing an extended half-life RSV F mAb directed against the newly identified antigenic site \u00d8 to protect infants through their first RSV season.",
            "startOffset": 41897,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 32039,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "To better protect these infants, maternal/passive immunization has become a greater priority.",
            "startOffset": 31946,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 37001,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 37000,
                    "startOffset": 36996
                }
            },
            "secId": "sec0020",
            "sentence": "A binding competition assay is being used to measure antibodies able to compete with palivizumab for binding to the RSV F protein [26].",
            "startOffset": 36866,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 29451,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A modified version of the D25 mAb, which is specific for the neutralizing epitope in antigenic site \u00d8 on the pre-F conformation of RSV F protein is being developed for passive prophylaxis in pediatric populations.",
            "startOffset": 29238,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 39400,
            "parents": [],
            "secId": "sec0025",
            "sentence": "As of December 2015, 60 RSV vaccine candidates are in preclinical or clinical development and encompass five broad platforms (Table 1).",
            "startOffset": 39265,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 34773,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "The pathway could be accelerated by integrating high-income country and LMIC clinical development, as immunization during pregnancy is more widely accepted and adopted in the developing world.",
            "startOffset": 34581,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 36734,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "A recent survey study across 12 divergent neutralization assay formats testing a common sample panel demonstrated feasibility for harmonization of output by use of a standard.",
            "startOffset": 36559,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 37897,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 37896,
                    "startOffset": 37893
                }
            },
            "secId": "sec0020",
            "sentence": "Another key component of Phase 3 trials, consensus case definitions/severity scoring systems, are being drafted and discussed [6].",
            "startOffset": 37767,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 43110,
            "parents": [],
            "secId": "sec0025",
            "sentence": "The successful global Maternal and Neonatal Tetanus Elimination Initiative, the recent recommendation by WHO that pregnant women be the highest priority group for influenza vaccine, and the recent recommendation for maternal immunization to protect infants from pertussis by the US Advisory Committee on Immunization Practices all provide important precedents for the acceptance and justification of a maternal immunization approach.",
            "startOffset": 42677,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 34172,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 34171,
                    "startOffset": 34167
                }
            },
            "secId": "sec0020",
            "sentence": "The World Health Organization (WHO) Consultation on Respiratory Syncytial Virus Vaccine Development held March 23\u201324, 2015 concluded that safety, immunogenicity, and efficacy data in preclinical models (including those that exhibit enhanced disease immunopathology such as the mice, rat, cotton rat, bovine, and baboon models) should be reviewed when considering the advancement of a vaccine candidate into the clinic [25].",
            "startOffset": 33749,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 35671,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Since no animal model can absolutely rule out the risk of ERD, advancing vaccine development for vectored vaccines from a seropositive toddler to seronegative infant population involves some level of risk.",
            "startOffset": 35466,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 30981,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Either of these strategies could be followed with active infant immunization later in life as maternal/passive antibody titers wane.",
            "startOffset": 30849,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 30625,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "The need for immediate protection and the difficulty of achieving protective efficacy via active immunization in this age group has made maternal immunization and infant passive prophylaxis a priority strategy for protecting young infants.",
            "startOffset": 30386,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 34406,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 34405,
                    "startOffset": 34402
                }
            },
            "secId": "sec0020",
            "sentence": "Early trials that involve seronegative infants should occur in a setting with appropriate facilities for the management of adverse events [6].",
            "startOffset": 34264,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 40443,
            "parents": [],
            "secId": "sec0025",
            "sentence": "GSK (Phase 1) is testing an adenovirus prime/boost candidate for use in children beyond the neonatal period.",
            "startOffset": 40335,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 33748,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "The regulatory pathways for RSV vaccines are defined by the following requirements: (1) to establish evidence of protection against RSV disease affecting the very youngest age group; (2) to provide additional ERD safety assurances for an infant vaccine; (3) to generate safety information about the different technologies used (i.e., live, non-replicating, vectored, subunit antigen, extended half-life mAb); and (4) to chart a relatively new pathway if pursuing a maternal indication, which requires immunizing one group and measuring outcomes in another.",
            "startOffset": 33192,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 40913,
            "parents": [],
            "refoffsets": {
                "bib0310": {
                    "endOffset": 40912,
                    "startOffset": 40908
                }
            },
            "secId": "sec0025",
            "sentence": "Recent advances in understanding RSV F protein structure and instability could inform vaccine development [30].",
            "startOffset": 40802,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 37617,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Correlates of protection against severe disease in young infants may differ by type of vaccine used and will need to be evaluated in the context of efficacy trials.",
            "startOffset": 37453,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 38093,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "These systems include clinical features that are considered objective, easily standardized, generalizable to multiple global settings, and based on generally accepted markers of disease severity.",
            "startOffset": 37898,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 32389,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A maternal vaccination strategy will be just as important, but, like mAbs, will be limited to the very young and will not protect children beyond four to six months of age.",
            "startOffset": 32217,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 41677,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Novavax is advancing a rosetted post-F for their elderly, maternal immunization, and pediatric vaccine candidates.",
            "startOffset": 41563,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 27988,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Protein-based vaccine approaches (including whole-inactivated virus, subunit antigens that associate to form aggregate particles, and non-particle based subunit antigens) have been developed for protecting elderly populations from severe disease and are often formulated with an adjuvant.",
            "startOffset": 27700,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 40602,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Janssen Pharmaceutical (Phase 1) and Bavarian Nordic (Phase 1) advanced to the clinic in 2015 with their own adenovirus and MVA vaccine products respectively.",
            "startOffset": 40444,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 28491,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Maternal RSV vaccines will likely be more acceptable either as unadjuvanted formulations or adjuvanted only with alum given their history of safe use in this population.",
            "startOffset": 28322,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 41009,
            "parents": [],
            "secId": "sec0025",
            "sentence": "RSV F is present on the viral surface in two states: a metastable pre-F and stable post-F form.",
            "startOffset": 40914,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 30385,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 30384,
                    "startOffset": 30377
                },
                "bib0265": {
                    "endOffset": 30384,
                    "startOffset": 30377
                }
            },
            "secId": "sec0015",
            "sentence": "The incidence of severe RSV disease is highest in infants younger than six months of age [10,21].",
            "startOffset": 30288,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 33059,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 33058,
                    "startOffset": 33054
                }
            },
            "secId": "sec0015",
            "sentence": "It is also not well understood how much an RSV vaccine will impact the incidence of secondary respiratory bacterial infection [24].",
            "startOffset": 32928,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 24170,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Older adults are at risk for more severe RSV disease.",
            "startOffset": 24117,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 35465,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Development pathways for active infant vaccination using novel vectored approaches could involve age de-escalation safety studies.",
            "startOffset": 35335,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 24690,
            "parents": [],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 24689,
                    "startOffset": 24686
                }
            },
            "secId": "sec0005",
            "sentence": "Furthermore, prophylactic administration of monoclonal or polyclonal antibodies reduces the incidence of severe RSV disease in children [9].",
            "startOffset": 24550,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 30848,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A maternal immunization approach would be intended to protect infants for the first two to six months of life.",
            "startOffset": 30738,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 23671,
            "parents": [],
            "secId": "sec0005",
            "sentence": "While there is currently no licensed vaccine for RSV, several observations support the feasibility for RSV vaccine development:",
            "startOffset": 23544,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 28755,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Replication competent and deficient alphavirus, adenovirus, and modified vaccinia virus Ankara (MVA) vectors encoding RSV surface antigens (including replication-competent and -deficient variations) are being developed for use in infant and pediatric populations.",
            "startOffset": 28492,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 37766,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Regulatory alignment on measurements of disease severity and definitions are important to allow for the advancement of vaccine development programs.",
            "startOffset": 37618,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 28120,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Particles can display viral proteins, peptides, or neutralizing epitopes with increased density to enhance B cell receptor binding.",
            "startOffset": 27989,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 30737,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A goal of passive immunoprophylaxis is to provide four to six months of protection with a single dose antibody.",
            "startOffset": 30626,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 25470,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Recent progress defining the RSV pre-F protein structure, and identification of several neutralizing epitopes found only on pre-F, improve the likelihood for making a potent vaccine.",
            "startOffset": 25288,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 26567,
            "parents": [],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 26566,
                    "startOffset": 26559
                },
                "bib0255": {
                    "endOffset": 26566,
                    "startOffset": 26559
                },
                "bib0260": {
                    "endOffset": 26566,
                    "startOffset": 26559
                }
            },
            "secId": "sec0010",
            "sentence": "Enhanced respiratory disease (ERD) has been recapitulated in several animal models, including mice, cotton rats, bovine calves, and African green monkeys [18\u201320].",
            "startOffset": 26405,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 24116,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Preventing RSV-associated ALRI in the youngest populations, therefore, may be an achievable goal.",
            "startOffset": 24019,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 31945,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "To reduce the burden of childhood pneumonia, there is strong consensus that focus should be placed on children in their first six months of life, when the risk of severe RSV-associated respiratory disease is highest.",
            "startOffset": 31729,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 36865,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Plans for establishing this IS are being developed by WHO and the National Institute for Biological Standards and Control (NIBSC).",
            "startOffset": 36735,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 39588,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Live-attenuated approaches targeting pediatric populations have been in development for decades, spearheaded by the US National Institute of Allergy and Infectious Diseases and MedImmune.",
            "startOffset": 39401,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 25718,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 25717,
                    "startOffset": 25710
                },
                "bib0220": {
                    "endOffset": 25717,
                    "startOffset": 25710
                },
                "bib0225": {
                    "endOffset": 25717,
                    "startOffset": 25710
                },
                "bib0230": {
                    "endOffset": 25717,
                    "startOffset": 25710
                }
            },
            "secId": "sec0010",
            "sentence": "The history of RSV vaccine development is notable for the vaccine-enhanced illness that occurred after a formalin-inactivated RSV (FI-RSV) vaccine was administered to seronegative infants in the 1960s [11\u201314].",
            "startOffset": 25509,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 24413,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The ability of RSV-specific functional antibodies to neutralize viral infection has been demonstrated in vitro.",
            "startOffset": 24302,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 38224,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Endpoints for licensure should include safety and reduction of severe disease, but also assess impact on mild or moderate disease.",
            "startOffset": 38094,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 38753,
            "parents": [],
            "secId": "sec0025",
            "sentence": "The success of passive immunization with an RSV F mAb (palivizumab and motavizumab) provides the rationale for developing a vaccine that elicits functional antibody responses.",
            "startOffset": 38578,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 32927,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "As the mechanism is not understood, the benefit of an RSV vaccine for asthma outcomes is not clear.",
            "startOffset": 32828,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 34263,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "In general, safety and immunogenicity studies should first be performed in healthy adults.",
            "startOffset": 34173,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 43529,
            "parents": [],
            "secId": "sec0030",
            "sentence": "While some RSV burden data are available, additional information is needed to inform evidence-based decisions \u2013 particularly mortality, morbidity, and cost of illness data from LMICs.",
            "startOffset": 43346,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 28321,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Particle and protein-subunit vaccines are also being developed for immunization during pregnancy to boost pre-existing immunity to increase transplacental transfer of RSV-specific antibody to infants.",
            "startOffset": 28121,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 38397,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Once licensure is obtained, advancing to WHO prequalification rapidly is critical because the most severe disease occurs in the countries with greater resource constraints.",
            "startOffset": 38225,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 42676,
            "parents": [],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 42675,
                    "startOffset": 42672
                }
            },
            "secId": "sec0025",
            "sentence": "Platforms exist for vaccine delivery to pregnant women that leverage the likelihood that, even in the least-developed countries, the majority of women will have some antenatal care [6].",
            "startOffset": 42491,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 25287,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Live-attenuated and inactivated virus vaccines have been successfully developed for influenza, a more mutable and antigenically variable respiratory virus than RSV, though both share some virologic and clinical similarities.",
            "startOffset": 25063,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 36139,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "For all clinical development strategies, assessing safety and immunogenicity during co-administration with representative routine vaccines appropriate for the targeted recipients would be necessary.",
            "startOffset": 35941,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 41144,
            "parents": [],
            "refoffsets": {
                "bib0315": {
                    "endOffset": 41143,
                    "startOffset": 41139
                }
            },
            "secId": "sec0025",
            "sentence": "The newly characterized antigenic site \u00d8 has been shown to elicit antibodies more potent than palivizumab in preclinical studies [31].",
            "startOffset": 41010,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 38873,
            "parents": [],
            "secId": "sec0025",
            "sentence": "While antibodies to F protein are cross-reactive across RSV A and B subtypes, antibodies to G protein are much less so.",
            "startOffset": 38754,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 39901,
            "parents": [],
            "secId": "sec0025",
            "sentence": "While the majority of the vaccine candidates under development are still in the preclinical stage, 16 candidates are now in clinical development.",
            "startOffset": 39756,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 36558,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Harmonization across formats using an international antibody standard (IS) could facilitate the comparison and prioritization of RSV vaccine candidates.",
            "startOffset": 36406,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 23812,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Primary RSV infection occurs in most infants within the first two years of life, with virtually all children infected by three years of age.",
            "startOffset": 23672,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 31511,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A live vaccine approach targeted to older infants and young children could ultimately complement a maternal/passive immunization approach by protecting these older populations and decreasing transmission of the virus.",
            "startOffset": 31294,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 39264,
            "parents": [],
            "secId": "sec0025",
            "sentence": "The efficacy of palivizumab and motavizumab, which bind to antigenic site II on the RSV F protein, has led many developers to focus on RSV F as a primary immunogen.",
            "startOffset": 39100,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 30065,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "To achieve this goal, increased awareness and data on RSV disease burden in LMICs is needed, particularly to inform policy makers, regulators, and societies on the potential benefits of vaccine development.",
            "startOffset": 29859,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 29858,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0185": {
                    "endOffset": 29857,
                    "startOffset": 29854
                }
            },
            "secId": "sec0015",
            "sentence": "A reduction in the incidence and severity of RSV-related ALRI in children younger than five years of age through vaccination in low- and middle-income countries (LMICs) would directly work toward reaching the fourth Millennium Development Goal of reducing child mortality [5].",
            "startOffset": 29582,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 43345,
            "parents": [],
            "secId": "sec0030",
            "sentence": "Since the focus of RSV vaccine development in LMICs will be on protecting infants and children younger than five years of age, the vaccines will be in line with the priorities set by Gavi, the Vaccine Alliance.",
            "startOffset": 43135,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 42490,
            "parents": [],
            "secId": "sec0025",
            "sentence": "The success of a maternal immunization strategy will require access to and acceptability of vaccination in pregnant women.",
            "startOffset": 42368,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 39959,
            "parents": [],
            "secId": "sec0025",
            "sentence": "Several of these utilize an RSV F protein-based approach.",
            "startOffset": 39902,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 41285,
            "parents": [],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 41284,
                    "startOffset": 41280
                }
            },
            "secId": "sec0025",
            "sentence": "In addition, there are at least two other sites exclusive to pre-F (AM14 and MPE8) that are more neutralization sensitive than site II [32].",
            "startOffset": 41145,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 43730,
            "parents": [],
            "secId": "sec0030",
            "sentence": "In addition, methods to increase the accuracy of infant mortality data in countries where an appreciable number of home deaths result in underreporting would facilitate case building for RSV vaccines.",
            "startOffset": 43530,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 37273,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "The palivizumab competitive antibody (PCA) assay shows promise as a means to characterize antibody responses to the RSV F site II neutralizing epitope, one of many neutralizing epitopes on the F protein, but does not ensure that the competing antibodies are neutralizing.",
            "startOffset": 37002,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 28951,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "These vectors are intended to express surface proteins in their authentic conformation and are processed by MHC class I and class II pathways, thus eliciting robust humoral and cellular immunity.",
            "startOffset": 28756,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 24549,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 24548,
                    "startOffset": 24545
                }
            },
            "secId": "sec0005",
            "sentence": "Protection has been demonstrated in numerous preclinical models (i.e., mouse, cotton rat, guinea pig, calf, and non-human primate) [8].",
            "startOffset": 24414,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 31068,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Numerous live-attenuated and chimeric virus RSV vaccine approaches are being developed.",
            "startOffset": 30981,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 32827,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0275": {
                    "endOffset": 32826,
                    "startOffset": 32822
                }
            },
            "secId": "sec0015",
            "sentence": "RSV may precipitate the development of asthma or simply be worse in those who are predisposed to asthma [23].",
            "startOffset": 32718,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 35005,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "RSV mAb trials may be able to more easily recruit participants given the effectiveness of palivizumab, the existence of an established clinical and regulatory pathway, and the fact that pregnant women will not have to be immunized.",
            "startOffset": 34774,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 38545,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Therefore, the definition of endpoints relevant to LMIC populations and efficacy data from these settings should be planned for in efficacy trials.",
            "startOffset": 38398,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 36405,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Numerous neutralization assay formats have been developed to measure functional antibodies against both RSV A and B subtypes.",
            "startOffset": 36280,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 39099,
            "parents": [],
            "secId": "sec0025",
            "sentence": "However, antibodies to the neutralizing site in the central conserved region of G should work on both subtypes, while antibodies binding the heavily glycosylated regions of G do not neutralize and would not be cross-reactive.",
            "startOffset": 38874,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 26865,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Consequently, only live-attenuated vaccines have been tested for active infant immunization for the last four decades.",
            "startOffset": 26747,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 29107,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Nucleic acid vaccines using either plasmid DNA or messenger RNA encoding RSV antigens are being targeted to protect both pediatric and elderly populations.",
            "startOffset": 28952,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 41896,
            "parents": [],
            "secId": "sec0025",
            "sentence": "GSK's 2015 acquisition of Novartis Vaccines has united five RSV vaccine candidates using three technologies (pre- and post-F subunit protein, nucleic acid, and gene-based vector) into a single organizational portfolio.",
            "startOffset": 41678,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 41430,
            "parents": [],
            "secId": "sec0025",
            "sentence": "The stabilization of pre-F and its subsequent demonstration of potent immunogenicity has enabled testing of this protein as a vaccine candidate.",
            "startOffset": 41286,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 31293,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 31292,
                    "startOffset": 31288
                }
            },
            "secId": "sec0015",
            "sentence": "Achieving a proper balance between attenuation (safety) and immunogenicity, as well as genetic stability, has been difficult, although recent advances with recombinantly engineered RSV suggest that this may be feasible [22].",
            "startOffset": 31069,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 35940,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "An NIH/FDA RSV vaccine workshop held June 1\u20132, 2015 concluded studies in seropositive children would not provide any assurance of safety of subunit or inactivated vaccines for RSV-na\u00efve children, such that there is no clear development path forward for such endeavors.",
            "startOffset": 35672,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 32216,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Protection of preterm infants with palivizumab and motavizumab has already been demonstrated and likely will show the same for the next generation of RSV F mAbs in development.",
            "startOffset": 32040,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 24301,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 24300,
                    "startOffset": 24297
                }
            },
            "secId": "sec0005",
            "sentence": "The reason may be multifactorial and could be attributable to underlying cardiac or pulmonary disease and/or immunosenescence [2].",
            "startOffset": 24171,
            "title": "Feasibility for vaccine development"
        },
        {
            "endOffset": 33191,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "Overall, 16 RSV candidates are currently advancing through Phase 1 to Phase 3 clinical trials.",
            "startOffset": 33097,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 37452,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 37451,
                    "startOffset": 37444
                },
                "bib0300": {
                    "endOffset": 37451,
                    "startOffset": 37444
                },
                "bib0305": {
                    "endOffset": 37451,
                    "startOffset": 37444
                }
            },
            "secId": "sec0020",
            "sentence": "In passive prophylaxis studies with RSV-IGIV in rodents and infants, high titers of serum neutralizing antibody correlated with protection of the lower respiratory tract [27\u201329].",
            "startOffset": 37274,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 29237,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "Combination approaches with DNA and protein are in early development as well and could induce both cellular and humoral immunity.",
            "startOffset": 29108,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 36279,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "A commercial RSV IgG ELISA assay from IBL International evaluates immunogenicity of F and G proteins, but does not assess antibody function.",
            "startOffset": 36139,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 26266,
            "parents": [],
            "secId": "sec0010",
            "sentence": "Proposed mechanisms for disease enhancement include the induction of high titers of non-neutralizing antibodies and Th2-biased cellular immune profile.",
            "startOffset": 26115,
            "title": "Constraints on RSV vaccine development"
        },
        {
            "endOffset": 35212,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0020",
            "sentence": "However, if the intervention is intended for all, not just children at high risk of severe disease, requirements for showing the mAb is safe and free of any developmental or off-target effects will be high.",
            "startOffset": 35006,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 27046,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "A growing number of RSV vaccine candidates, across multiple platforms, has emerged as of late.",
            "startOffset": 26952,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        },
        {
            "endOffset": 30288,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Constraints on RSV vaccine development"
                }
            ],
            "secId": "sec0015",
            "sentence": "In recognition of differing risk and immune profiles, vaccine development will likely have to follow a two-pronged approach that divides the target population into two age groups \u2013 younger and older than six months of age.",
            "startOffset": 30066,
            "title": "General approaches to vaccine development for low- and middle-income country markets"
        }
    ],
    "docId": "S0264410X16301682",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "dhiggins@path.org",
                "first": "Deborah",
                "initial": "D.",
                "last": "Higgins"
            },
            {
                "email": null,
                "first": "Carrie",
                "initial": "C.",
                "last": "Trujillo"
            },
            {
                "email": null,
                "first": "Cheryl",
                "initial": "C.",
                "last": "Keech"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.03.109",
        "firstpage": "2870",
        "issn": "0264410X",
        "keywords": [
            "Research and development",
            "Respiratory syncytial virus",
            "Vaccine"
        ],
        "lastpage": "2875",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Advances in RSV vaccine research and development - A global agenda"
    }
}